Product Information
DIALYVITE 3,000 TABLET is a generic product labeled by Hillestad Pharmaceuticals USA, priced at $0.2842 per EA under NDC 10542001409. Its NADAC has been published 68 times since Jun 18, 2025.
DIALYVITE 3,000 TABLET
Ascorbic Acid, Tocopheryl Acid Succinate, Thiamine, Riboflavin, Niacinamide, Pyridoxine, Folic Acid, Cobalamin, Biotin, Pantothenic Acid, Zinc, SeleniumStrength
30; 100; 300; 10; 1; 3; 20; 25; 1.7; 70; 1.5; 15 [iU]/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1
Manufacturer
Hillestad Pharmaceuticals USANDC
10542001409
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Approval Type
Unapproved
On Market Since
2/1/2004
Pharmacological Classes
Price Statistics
The NADAC for DIALYVITE 3,000 TABLET has been published 68 times since Jun 18, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2842 per EA |
|---|---|
| All-time high | $0.2967 (Dec 10, 2025) |
| All-time low | $0.2804 (Apr 22, 2026) |
| 52-week high | $0.2967 |
| 52-week low | $0.2804 |
| Median price | $0.2905 |
| Average price | $0.2887 |
| Largest weekly change | -4.3% (Apr 22, 2026) |
| Weeks tracked | 68 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ascorbic Acid, Tocopheryl Acid Succinate, Thiamine, Riboflavin, Niacinamide, Pyridoxine, Folic Acid, Cobalamin, Biotin, Pantothenic Acid, Zinc, Selenium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hillestad Pharmaceuticals USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ascorbic Acid, Tocopheryl Acid Succinate, Thiamine, Riboflavin, Niacinamide, Pyridoxine, Folic Acid, Cobalamin, Biotin, Pantothenic Acid, Zinc, Selenium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Copper Absorption Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIALYVITE 3,000 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIALYVITE 3,000 TABLET, manufactured by Hillestad Pharmaceuticals USA, is $0.2842 per EA (NDC 10542001409), effective Sep 30, 2026.
How has the price of DIALYVITE 3,000 TABLET changed over time?
Over the history we have for it, the NADAC for DIALYVITE 3,000 TABLET has held within roughly two percent of its current level. It has been tracked across 68 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for DIALYVITE 3,000 TABLET?
Since Jun 18, 2025, the NADAC for DIALYVITE 3,000 TABLET has ranged from a low of $0.2804 (Apr 22, 2026) to a high of $0.2967 (Dec 10, 2025), with a median of $0.2905 per EA.
Are there cheaper alternatives to DIALYVITE 3,000 TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DIALYVITE 3,000 TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DIALYVITE 3,000 TABLET?
DIALYVITE 3,000 TABLET (NDC 10542001409) is labeled by Hillestad Pharmaceuticals USA, and CMS classifies it as a generic product.